Literature DB >> 7251310

Diabetes mellitus and the rabbit corneal epithelium.

J Friend, T C Kiorpes, R A Thoft.   

Abstract

Diabetes mellitus has been shown to be a factor in the development of corneal epithelial abnormalities in stressed human eyes, but the biochemical basis for this is not known. To see if sorbitol pathway activation might be involved, ocular surface epithelial healing rates and metabolites of the glycolytic and sorbitol pathways were measured in alloxan-diabetic rabbits. As in humans, corneal epithelial healing rates were not decreased in the diabetic rabbits, suggesting that the rabbit may be an appropriate model for human disease. Increased levels of glucose, glycogen, and sorbitol were found in the diabetic corneal epithelium compared with normal. However, the sorbitol accumulation only mounted to 1.0 mOsm/L of tissue water, which implies that osmotic damage secondary to corneal epithelial cell sorbitol accumulation might not be a significant factor in corneal epithelial abnormalities of diabetes.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7251310

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  4 in total

1.  Kinematics of epithelial wound closure in the rabbit cornea.

Authors:  L S Kwok
Journal:  Doc Ophthalmol       Date:  1991       Impact factor: 2.379

Review 2.  Corneal reepithelialization and anti-inflammatory agents.

Authors:  B D Srinivasan
Journal:  Trans Am Ophthalmol Soc       Date:  1982

3.  Topical application of naltrexone facilitates reepithelialization of the cornea in diabetic rabbits.

Authors:  I S Zagon; Joseph W Sassani; Melissa A Carroll; Patricia J McLaughlin
Journal:  Brain Res Bull       Date:  2009-10-21       Impact factor: 4.077

Review 4.  Dry Eye Syndrome in Patients with Diabetes Mellitus: Prevalence, Etiology, and Clinical Characteristics.

Authors:  Xinyuan Zhang; Lin Zhao; Shijing Deng; Xuguang Sun; Ningli Wang
Journal:  J Ophthalmol       Date:  2016-04-26       Impact factor: 1.909

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.